LONDON--(EON: Enhanced Online News)--According to the latest market study released by Technavio, the global thrombectomy devices market is expected to grow at a CAGR of close to 6% during the forecast period.
This research report titled ‘Global Thrombectomy Devices Market 2016-2020’ provides an in-depth analysis of the market in terms of revenue and emerging market trends. This market research report also includes up to date analysis and forecasts for various market segments and all geographical regions.
One of the key drivers of this market is the acquisition of small specialized hospitals by tier-1 hospitals. This has led to increased patient care management, which has led to the positive growth of the thrombectomy devices market. This is mainly due to the better training that the tier-1 hospitals are able to provide to their staff, including physicians and nurses. With the training, a better diagnosis and treatment of peripheral artery diseases (PADs) is ensured.
Other key drivers that are responsible for the growth of this market are the increasing product approvals and patents, and a rise in prevalence of cardiovascular and cerebrovascular diseases. Geographically, the Americas lead the market with a market share of 45% in 2015. This dominance is due to high standards of healthcare and the increasing incidences of lifestyle diseases among the general population.
Request a sample report: http://www.technavio.com/request-a-sample?report=55084
Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.
Based on product segment, the report categorizes the thrombectomy devices market into the following segments:
- Mechanical thrombectomy devices
- Aspiration thrombectomy devices
- Rheolytic thrombectomy devices
Mechanical thrombectomy devices
“Mechanical thrombectomy devices remain the gold standard for thrombolysis, as it is one of the oldest methods for the treatment of blood clot in arteries. The segment generates the highest revenue for the thrombectomy devices market, due to surgeon preference and ease of device use. Combined with rising public awareness for the early diagnosis of PAD and related disorders, this segment is expected to continue its dominance through the forecast period,” says Srinivas Sashidhar, one of the lead analysts at Technavio for cardiovascular diseases research.
Analysts at Technavio expect the mechanical thrombectomy devices market to grow at a steady rate during the forecast period. Solitaire FR Revascularization and Mechanical Embolus Removal in Cerebral Ischemia (Merci) are two of the most common mechanical thrombectomy devices used. These devices have proved to be efficient in the treatment of acute strokes and have ensured patient safety during the recanalization process. Despite this, they are expected to face neck-to-neck competition with aspiration and rheolytic thrombectomy devices.
Aspiration thrombectomy devices
Aspiration thrombectomy devices have been used for percutaneous coronary intervention (PCI) procedures and it can help in preventing distal embolization. Despite numerous studies conducted on its efficacy, the verdict remains biased, with an equal number of positive and negative feedbacks. Key vendors are focusing in the development of aspiration thrombectomy devices with better clinical capabilities and high success rates in the recovery of patients.
The aspiration thrombectomy devices market is expected to grow at a swift rate when compared to the mechanical thrombectomy devices market. The use of aspiration techniques for clot retrieval is considered as an advantage for clot removal. However, trials are underway to test and improve the efficiency for the removal of large thrombus. The future prospects of these devices are expected to help in leading the market growth.
Rheolytic thrombectomy devices
One of the most widely used rheolytic thrombectomy devices is the AngioJet Rheolytic Thrombectomy System by Boston Scientific. The process combines the delivery of clot-busting thrombolytic drugs with the mechanical thrombectomy procedure to successfully extract the thrombus. This type of device aims to reduce the overall cost of drug-eluting stents, late stent thrombosis, and also has the potential to reduce distal embolization. Clinical trials have proven it to be a safer, more effective, and efficient thrombectomy procedure.
“The development of rheolytic device combined with mechanical thrombectomy devices for clot retrieval is the focus area for key vendors. This would help in the reduction of economic burden, enhanced treatment of myocardial infarction, and emergency bypass surgery. This translates to a healthy growth of the rheolytic thrombectomy devices market. These devices are also expected to eliminate the need for the administration of clot removal drugs,” says Srinivas.
The top vendors highlighted by Technavio’s research analysts in this report are:
- Boston Scientific
- DePuy Synthes
Browse Related Reports:
- Global Atherectomy Devices Market 2016-2020
- Global Peripheral Vascular Diagnostics Systems Market 2016-2020
- Global Vascular Closure Devices Market 2016-2020
Become a Technavio Insights member and access all three of these reports for a fraction of their original cost. As a Technavio Insights member, you will have immediate access to new reports as they’re published in addition to all 6,000+ existing reports covering segments like cardiovascular and metabolic devices, in-vitro diagnostics, and oncology. This subscription nets you thousands in savings, while staying connected to Technavio’s constant transforming research library, helping you make informed business decisions more efficiently.
Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.
Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, re-sellers, and end-users.
If you are interested in more information, please contact our media team at firstname.lastname@example.org.